UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 進行癌患者における骨吸収抑制薬による薬剤療法のリスクrisks of therapy with bone antiresorptive agents in patients with advanced malignancy [show details]
…those who stopped placebo treatment . Potent bisphosphonate therapy (ie, zoledronic acid for at least one dose) after stopping denosumab therapy is recommended to prevent rebound bone loss and fractures …
2. 放射性ヨウ素による甲状腺機能亢進症の治療radioiodine in the treatment of hyperthyroidism [show details]
… postradioiodine administration. Resumption of thionamide therapy three to seven days after radioiodine administration has been shown to result in less post-therapy rebound hyperthyroidism . While a postradioiodine increase …
3. 統合失調型パーソナリティ障害の治療法approach to treating schizotypal personality disorder [show details]
…performance, amnesia, addiction and withdrawal symptoms after long-term treatment, and rebound anxiety after short-term treatment. Benzodiazepines should not be used in those with an active substance use …
4. 成人における全般性不安障害の治療法に対するアプローチapproach to treating generalized anxiety disorder in adults [show details]
…after long-term treatment, and rebound anxiety after short-term treatment . The use of benzodiazepines to treat agitation or insomnia caused or exacerbated by antidepressant treatment is discussed above …
5. サイトメガロウイルス感染の診断へのアプローチapproach to the diagnosis of cytomegalovirus infection [show details]
…appropriate therapy, or a rebound in viral load after an initial response should be evaluated for drug resistance. An increase or lack of reduction of viral load during the first two weeks of therapy is not …